Inqtspas M 80mg/250mg Tablet
Marketer
Incuity Pharma Pvt. Ltd.
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Inqtspas M 80mg/250mg Tablet
Abdominal pain relief is provided by the combined medication Inqtspas M 80mg/250mg Tablet. This formulation effectively alleviates abdominal pain, bloating, discomfort, and cramping by inducing relaxation of the stomach and intestinal muscles. It simultaneously inhibits specific pain-inducing neurotransmitters. Administered with food, dosage and treatment duration for Inqtspas M 80mg/250mg Tablet are determined by your physician. Treatment length is dependent on your individual response and condition. Premature cessation may result in symptom recurrence and condition exacerbation. Inform your healthcare provider of all concurrent medications, as interactions may occur. Common side effects include diarrhea, nausea, vomiting, stomach upset, dry mouth, appetite loss, thirst, and heartburn; most are transient and self-limiting. Report any concerning side effects immediately. Dizziness and drowsiness are possible; avoid driving or activities requiring concentration until effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Disclose pregnancy, pregnancy plans, or breastfeeding to your doctor prior to use. Kidney or liver conditions should also be reported to ensure appropriate dosage.
Uses of Inqtspas M 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Inqtspas M 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Inqtspas M 80mg/250mg Tablet whole; do not chew, crush, or fracture it. It should be administered with food.
Common Side effects of Inqtspas M 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Inqtspas M 80mg/250mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Swallow the Inqtspas M 80mg/250mg tablet whole; avoid chewing, crushing, or breaking it. It should be administered with a meal.
How Inqtspas M 80mg/250mg Tablet works:
Inqtspas M, an 80mg/250mg tablet, combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle contractions. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of pain and inflammation-inducing chemical signals.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Inqtspas M 80mg/250mg tablets; it's dangerous.
PregnancyCONSULT YOUR DOCTOR
Using Inqtspas M 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Inqtspas M 80mg/250mg Tablet with breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Inqtspas M 80mg/250mg Tablets, a potential side effect of this medication due to the risk of vertigo.
KidneyCAUTION
Patients with kidney impairment should use Inqtspas M 80mg/250mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Inqtspas M 80mg/250mg tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Inqtspas M 80mg/250mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Inqtspas M 80mg/250mg Tablet :
Should you forget a dose of Inqtspas M 80mg/250mg Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Inqtspas M 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently